These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 21427369)

  • 1. A practical approach for the validation and clinical implementation of a high-sensitivity cardiac troponin I assay across a North American city.
    Kavsak PA; Beattie J; Pickersgill R; Ford L; Caruso N; Clark L
    Pract Lab Med; 2015 Apr; 1():28-34. PubMed ID: 28932796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive cardiac troponin T assay.
    Lippi G; Cervellin G; Plebani M
    N Engl J Med; 2010 Apr; 362(13):1242; author reply 1243. PubMed ID: 20357290
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Sensitivity Cardiac Troponin I and T for Cardiovascular Risk Stratification in Adults With Diabetes.
    Tang O; Matsushita K; Coresh J; Ndumele C; McEvoy JW; Sharrett AR; Hoogeveen R; Ballantyne CM; Selvin E
    Diabetes Care; 2020 Oct; 43(10):e144-e146. PubMed ID: 32788284
    [No Abstract]   [Full Text] [Related]  

  • 5. Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification.
    de Antonio M; Lupón J; Galán A; Vila J; Zamora E; Urrutia A; Díez C; Coll R; Altimir S; Bayes-Genis A
    Clin Chim Acta; 2013 Nov; 426():18-24. PubMed ID: 23978483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly sensitive cardiac troponin T assay, cardiac disease, and mortality risk.
    Kavsak PA
    JAMA; 2011 Mar; 305(12):1196; author reply 1196-7. PubMed ID: 21427369
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac troponin assays in the management of heart failure.
    Torre M; Jarolim P
    Clin Chim Acta; 2015 Feb; 441():92-8. PubMed ID: 25545229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T.
    Sommerer C; Giannitsis E; Schwenger V; Zeier M
    Nephron Clin Pract; 2007; 107(3):c77-81. PubMed ID: 17890874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of cardiac biomarkers in end-stage renal disease.
    Wang AY; Lai KN
    J Am Soc Nephrol; 2008 Sep; 19(9):1643-52. PubMed ID: 18322158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of measurable cardiac troponin by high-sensitivity assays in patients with chronic stable heart failure.
    Latini R; Masson S
    Coron Artery Dis; 2013 Dec; 24(8):716-9. PubMed ID: 24162607
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.